Target Retina Centers Focus outreach on retina clinics, hospital ophthalmology networks, and trial sites in the AMD space to evaluate the MicroPump as a preferred delivery method for sight-saving therapies. Emphasize reduced patient visits, a predictable refill cadence, and potential for integrated data from remote monitoring to support clinical adoption.

Trial Partnerships Capitalize on ongoing clinical investigation by forming strategic alliances with CROs, trial sites, and academic medical centers to secure long-term supply agreements, service contracts, and real-world data that can support regulatory submissions and payer engagement.

Service and Logistics Offer end-to-end service models for clinics including implant support, programming, wireless recharge, refill logistics, and patient training, creating a recurring revenue stream beyond device sales.

Scale Partnerships Leverage the small team to partner with contract manufacturers, medical device distributors, and ophthalmic system integrators to scale production, regulatory support, and market access.

Market Readiness Position the MicroPump as a platform for ocular biotech therapies in an aging population with rising AMD therapy demand, while preparing for reimbursement discussions and demonstrating value through early clinical and economic wins.